Tevogen Bio Holdings Stock Is Soaring After Hours: What's Going On?

Tevogen Bio Holdings Inc TVGN shares are ripping higher in Monday’s after-hours session after the company reaffirmed its oncology pipeline revenue forecast.

What Happened: After the market close on Monday, Tevogen Bio reaffirmed its oncology pipeline outlook, forecasting $1 billion in revenue in its launch year. The company also projected cumulative five-year estimated sales in the range of $10 billion and $14 billion.

“With our intellectual property secured, Tevogen continues to build its U.S.-based cell therapy manufacturing capabilities, and I look forward to updating our shareholders on our forecasts and internal assets valuation,” said Ryan Saadi, founder and CEO of Tevogen Bio.

Tevogen Bio had a market cap of approximately $173.7 million as of Monday’s close. The company is set to hold its 2025 annual meeting of stockholders on June 23.

Check This Out: Amkor Technology Shares Climb After Q1 Revenue Beats, Q2 Revenue Guidance Above Estimates

How To Buy TVGN Stock

By now you're likely curious about how to participate in the market for Tevogen Bio — be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading — either way it allows you to profit off of the share price decline.

TVGN Price Action: Tevogen Bio shares were up 39.76% after-hours, trading at $1.31 at the time of publication Monday, according to Benzinga Pro data.

Photo: T. Schneider/Shutterstock.